Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

91.48 +1.31 (+1.45%)
Streaming Delayed Price Updated: 2:36 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,156,126
Open 90.65
Bid (Size) 91.47 (7)
Ask (Size) 91.51 (7)
Prev. Close 90.17
Today's Range 90.23 - 91.72
52wk Range 53.93 - 91.08
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?
Boston Scientific's latest trial shows safety and efficacy endpoints for stroke prevention in atrial fibrillation patients. 
Via Benzinga

Performance

YTD
+58.16%
+58.16%
1 Month
+3.90%
+3.90%
3 Month
+16.08%
+16.08%
6 Month
+21.37%
+21.37%
1 Year
+65.37%
+65.37%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
NYSE:BSX may be ready to breakout.
Via Chartmill
Don’t Confuse Brains With A Bull Market, Or Price With Value
Via Talk Markets
Why is Boston Scientific Stock Trading Lower On Wednesday?
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Via Benzinga
Behind the Scenes of Boston Scientific's Latest Options Trends
Via Benzinga
Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
Via Investor's Business Daily
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
Via Investor's Business Daily
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
Via Benzinga
Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
Via Benzinga
Boston Scientific's Options Frenzy: What You Need to Know
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Performance Comparison: Boston Scientific And Competitors In Health Care Equipment & Supplies Industry
Via Benzinga
Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?
Via Chartmill
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Via Benzinga
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
Via Benzinga
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
Via Benzinga
This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Solventum Stock Earns 81 RS Rating
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Via Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Via Benzinga
Topics Stocks
Exposures US Equities
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.